Stockopedia | Share Prices, Share News and Company Research

MOMENTUM
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d vs 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
GROWTH & VALUE

IMPLIED MARGIN OF SAFETY (beta)
SCREENS PASSED 3
Balance Sheet · Income Statement · Cashflow FINANCIAL SUMMARY
Year End 31st Dec 2007 2008 2009 2010 2011 2012 2013E 2014E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 20th Feb, paid: 30th May more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +19.7%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2012, Reckitt Benckiser Group Plc revenues increased 1% to L9.57B. Net income increased 5% to L1.83B. Revenues reflect Pharmaceuticals/RBP segment increase of 10% to L837M, Health & Personal Care segment increase of 3% to L2.07B, Hygiene segment increase of 1% to L3.68B, Latin America, North & South Asia, Newzealand (LAPAC) segment increase of 5% to L2.33B. more »

HEALTH TREND

BANKRUPTCY RISK

  EARNINGS MANIPULATION RISK

MAGIC FORMULA SCORE
A-
A-

OTHER RATIOS
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
RECENT HISTORY
Latest interim period (ended 31st Dec '12) vs. prior year
Sales Growth %
EPS Growth %
3yr Average Annualised
Sales Growth %
EPS Growth %
DPS Growth %

BROKER FORECASTS
31st Dec 2013
31st Dec 2014

Price Target: 4,576p (-6.01% below Price) Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: +5.0% (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
30 brokers BROKER CONSENSUS & FORECAST TREND
Broker Recommendations for Reckitt Benckiser
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 3 5 14 3 5

Named Brokers and Analysts
Jefferies & Company, Inc. Alex Howson , Credit Suisse Charlie Mills , Commerzbank Corporates & Markets Andreas Riemann , Sanford Bernstein Andrew Wood , Investec Bank (UK) Plc Martin Deboo , Canaccord Genuity Eddy Hargreaves , ING FM , Nomura Securities Guillaume Delmas , Panmure Gordon Graham Jones , Santander GBM , Collins Stewart & Co , Mirabaud Securities Julian Lakin , CA Cheuvreux , Societe Generale Chas Manso , Evolution Securities (Hist) , UniCredit Research , Berenberg Seth Peterson , Charles Stanley Tom Gidley-Kitchin , MF Global (Historical) , Raymond James Euro Equities Marc Willaume Hermine De Bentzmann , Shore Capital Stockbrokers Darren Shirley , Bryan Garnier , Espirito Santo Investment Bank Alex Smith , Morningstar, Inc. Erin Lash , Day by Day Valerie Gastaldy , Liberum Capital Pablo Zuanic , Alphavalue Armelle Moulin ,

Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries. The Company analyses its revenue based on health and personal care, fabric care, surface care, home care, dishwashing and other, together with pharmaceuticals and food. The Company’s geographical segments include: Europe, North America and Australia, Developing Markets and RB Pharmaceuticals. On February 4, 2011, it acquired a 50.1% interest in Manon Trading Company Limited (Manon). On April 11, 2011, the Company acquired Paras Pharmaceuticals Limited (Paras). The acquisition of Paras added products, such as Moov topical analgesic pain ointment, D’Cold cold/flu remedy, Dermicool for prickly heat and Krack medicated skin treatment for cracked heels. In December 2012, the Company's indirect subsidiary, Ascot Acquisition Corp. acquired Schiff Nutrition International Inc.

Directors: Rakesh Kapoor (CEO) , Adrian Hennah (CFO) 55, Heather Allen (Exec. VP) , Salvatore Caizzone (Exec. VP) , Freddy Caspers (Exec. VP) , Rob de Groot (Exec. VP) , Amedeo Fasano (Exec. VP) , Roberto Funari (Exec. VP) , Frederic Larmuseau (Exec. VP) , Simon Nash (Sr. VP) ,

No. of Employees: 35,900 No. of Shareholders: n/a


Last Annual December 31st, 2012
Last Interim December 31st, 2012
Shares in Issue 717,498,574
Free Float 633.8m (88.3%)

Address 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom
Web http://www.rb.com
Phone +44 1753 217800
Contact Richard Joyce (Director - Investor Relations)
Registrar Computershare Investor Services PLC (Bristol)
Auditors PricewaterhouseCoopers LLP

RB. SHARE PRICE PERFORMANCE RB. QUOTE
RB. Share Price GBp
4850p
Day's Change
-19.0  -0.4%
Traded 5:12pm · Minimum 15 min delayed

LATEST RB. NEWS ANNOUNCEMENTS (delayed)

UPCOMING RB. EVENTS
Monday 29th July, 2013
H1 2013 Reckitt Benckiser plc Earnings Release
Tuesday 22nd October, 2013
Reckitt Benckiser plc Interim Management Statement

Recent ↓
Thursday 2nd May, 2013
Reckitt Benckiser plc Annual Shareholder Meeting
Monday 22nd April, 2013
Q1 2013 Reckitt Benckiser plc Interim Management Statement Conference Call
Monday 22nd April, 2013
Q1 2013 Reckitt Benckiser plc Interim Management Statement
Wednesday 13th March, 2013
Reckitt Benckiser plc at Citi West Coast Institutional Investor Symposium
Wednesday 20th February, 2013
Dividend For RBGLY.PK
Wednesday 13th February, 2013
Q4 And Full Year 2012 Reckitt Benckiser plc Earnings Conference Call
Wednesday 13th February, 2013
Q4 And Full Year 2012 Reckitt Benckiser plc Earnings Release
Friday 16th November, 2012
Reckitt Benckiser plc Tender Offer To Acquire Outstanding Shares Of Schiff Nutrition International, Inc. Conference Call
Wednesday 24th October, 2012
Q3 2012 Reckitt Benckiser plc Earnings Release
Wednesday 24th October, 2012
Q3 2012 Reckitt Benckiser plc Earnings Conference Call


Should you buy RB.

Access RB. Analytics Now!

FREE TRIAL or TAKE THE TOUR